Literature DB >> 687657

On the mechanism for the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, of cholesterol 7alpha-hydroxylase and of acyl-coenzyme A:cholesterol acyltransferase by free cholesterol.

K A Mitropoulos, S Balasubramaniam, S Venkatesan, B E Reeves.   

Abstract

The administration of mevalonic acid to rats by intravenous injection resulted in a dose- and time-dependent increase in the activity of cholesterol 7alpha-hydroxylase in the liver microsomal fraction, a decrease in the microsomal activity of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and no significant change in the activity of acyl-coenzyme A:cholesterol acyltransferase or in the concentration of free and of esterified cholesterol in the liver microsomal fraction. However, the increased hepatic cholesterogenesis that follows the injection of mevalonic acid resulted in an increase of the size of the intracellular pool of cholesterol that is in the environment of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and acts as substrate for cholesterol 7alpha-hydroxylase. The administration of mevalonic acid to rats by stomach tube resulted in an increase in the activity of cholesterol 7alpha-hydroxylase and of acyl-coenzyme A:cholesterol acyltransferase and in the concentration of cholesterol esters in the liver microsomal fraction, while there was a considerable decrease in the activity of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 687657     DOI: 10.1016/0005-2760(78)90130-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  20 in total

1.  Regulation of Microsomal HMG-CoA Reductase by Enzyme-Lipid Interactions.

Authors:  V L Smith; L G Brent; M S Shabbot; R E Thompson
Journal:  Biophys J       Date:  1982-01       Impact factor: 4.033

2.  3-hydroxy-3-methylglutaryl-coenzyme A reductase A comparison of the modulation in vitro by phosphorylation and dephosphorylation to modulation of enzyme activity by feeding cholesterol- or cholestryamine-supplemented diets.

Authors:  K A Mitropoulos; B L Knight; B E Reeves
Journal:  Biochem J       Date:  1980-02-01       Impact factor: 3.857

3.  Regulation of neutral cholesterol esterase and acyl-CoA : cholesterol acyltransferase in the rat adrenal gland.

Authors:  D M Beins; R Vining; S Balasubramaniam
Journal:  Biochem J       Date:  1982-03-15       Impact factor: 3.857

4.  Evidence for phosphorylation/dephosphorylation of rat liver acyl-CoA:cholesterol acyltransferase.

Authors:  K L Gavey; D L Trujillo; T J Scallen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

5.  Cyclandelate. An inhibitor of cholesterol esterification.

Authors:  B Middleton; F Cacciaguerra; D White
Journal:  Drugs       Date:  1987       Impact factor: 9.546

6.  Very low density lipoprotein secretion by cultured hepatocytes of rabbits fed purified or autoxidized cholesterol.

Authors:  V A Kosykh; V Z Lankin; E A Podrez; D K Novikov; S A Volgushev; A V Victorov; V S Repin; V N Smirnov
Journal:  Lipids       Date:  1989-02       Impact factor: 1.880

7.  Independent regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and chylomicron remnant receptor activities in rat liver.

Authors:  D P Wade; A K Soutar; G F Gibbons
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

8.  In vivo regulation of rat liver 3-hydroxy-3-methylglutaryl-coenzyme A reductase: enzyme phosphorylation as an early regulatory response after intragastric administration of mevalonolactone.

Authors:  R E Arebalo; J E Hardgrave; B J Noland; T J Scallen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

9.  Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in rat liver and Morris hepatomas 5123C, 9618A and 5123t.c.

Authors:  R G Gregg; J R Sabine; P A Wilce
Journal:  Biochem J       Date:  1982-05-15       Impact factor: 3.857

10.  Serum lipoproteins and cholesterol metabolism in two hypercholesterolaemic rabbit models.

Authors:  N M O'Meara; R A Devery; D Owens; P B Collins; A H Johnson; G H Tomkin
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.